Committee Testimony and Witness Signup
HB0737 - Public Health - Nonopioid Advance Directives
Health and Government Operations 2/19/2025 1:00:00 PM
As of: 6/25/2025 8:55:41 AM
Name | Organization | Position | Testimony | Committee |
---|---|---|---|---|
Delegate Bagnall, Delegate Bagnall | FAV |
In Person - Oral Testimony |
HGO | |
Geddes, Ann | Mental Health Association of Maryland | FAV | HB0737_MHAMD_Fav.pdf | HGO |
Keller, Emily | Maryland's Office of Overdose Response | INFO | HB737 - MOOR - LOI.docx.pdf | HGO |
Bagnall, Heather | FAV |
In Person - Oral Testimony HB737_FAV_Sponsor.pdf |
HGO | |
Rosier, Collan | Pyramid Healthcare, Inc. | FAV | No Testimony | HGO |
Fiastro, John | FWA |
In Person - Oral Testimony |
HGO | |
Lykins, Deana | FWA |
In Person - Oral Testimony |
HGO | |
Morhaim, Dan | none | UNF | HB737 opposed.pdf | HGO |
Kauffman, Danna | UNF | HB0737_UNF_MedChi, MDACEP_PH - Nonopiod Advance Di | HGO | |
Jordan, Dr. Rachel | UNF |
In Person - Oral Testimony |
HGO | |
Lowe, Lisa | F.A.C.E. Addiction Maryland | FAV |
Virtual - Oral Testimony Association of Pharmaceutical Industry Marketing o Opioids Market Size to Worth Around USD 26.78 Bill Testimony - HB737 - Nonopioid Advance Directive.pd |
HGO |
Shimoda, Peggy | Hospice & Palliative Care Network of Maryland | UNF | HB0737_UNF_HPCNM.pdf | HGO |
Torsch, Toni | Daniel Carl Torsch Foundation | FAV | HB 737 - Favorable.pdf | HGO |
Validation
Please fix the following:
MyMGA
Accessibility Tools